Royal Philips (PHG) and Masimo (MASI) announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. The two companies are taking a new approach in accelerating the development and delivery of next-generation patient monitoring solutions. “We are excited to continue to partner with Philips to bring Masimo’s newest innovations in wearables and artificial intelligence to Philips’ platforms,” said Katie Szyman, CEO of Masimo. “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients. Together, Masimo and Philips will continue to empower clinicians to transform patient care.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Masimo, Philips announce multi-year renewal and expansion of partnership
- Philips launches smart telemetry platform for cardiac monitoring
- Philips launches Transcend Plus for EPIQ CVx, Affiniti CVx
- Philips announces plans for more than $150M manufacturing investment in U.S.
- Philips added to European Conviction List at Goldman Sachs
